Abstract |
The transplantation of the human T-cell acute lymphoblastic leukaemia ( T-ALL) cell line HSB-2 into severe combined immunodeficient (SCID) mice was found to produce a disseminated pattern of leukaemia similar to that seen in man. The intravenous injection of 10(7) HSB-2 cells was associated with a universally fatal leukaemia. Histopathological examination of animals revealed the spread of leukaemia initially from bone marrow to involve all major organs including the meninges. An immunotoxin (HB2-Sap) was constructed by conjugating the anti-CD7 MAb HB2 to the ribosome-inactivating protein saporin. An in vitro protein synthesis inhibition assay revealed specific delivery of HB2-Sap immunotoxin (IT) to CD7+ HSB-2 target cells with an IC50 of 4.5 pM. When SCID mice were injected with 10(6) HSB-2 cells and then treated 8 days later with a single intravenous dose of 10 micrograms of immunotoxin there was a significant therapeutic effect evidenced by the numbers of animals surviving in the therapy group compared with untreated controls (chi 2 = 5.348, P = 0.021). These results demonstrate the useful application of human leukaemia xenografts in SCID mice and the potential therapeutic effect of an anti-CD7 immunotoxin in human T-ALL.
|
Authors | B J Morland, J Barley, D Boehm, S U Flavell, N Ghaleb, J A Kohler, K Okayama, B Wilkins, D J Flavell |
Journal | British journal of cancer
(Br J Cancer)
Vol. 69
Issue 2
Pg. 279-85
(Feb 1994)
ISSN: 0007-0920 [Print] England |
PMID | 7507691
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Monoclonal
- Antigens, CD
- Antigens, CD7
- Antigens, Differentiation, T-Lymphocyte
- Immunotoxins
- Plant Proteins
- Ribosome Inactivating Proteins, Type 1
- N-Glycosyl Hydrolases
- Saporins
|
Topics |
- Animals
- Antibodies, Monoclonal
- Antigens, CD
(immunology)
- Antigens, CD7
- Antigens, Differentiation, T-Lymphocyte
(immunology)
- Humans
- Immunotoxins
(therapeutic use)
- In Vitro Techniques
- Leukemia-Lymphoma, Adult T-Cell
(pathology, therapy)
- Mice
- Mice, SCID
- N-Glycosyl Hydrolases
- Neoplasm Transplantation
- Plant Proteins
(therapeutic use)
- Ribosome Inactivating Proteins, Type 1
- Saporins
- Tumor Cells, Cultured
|